Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Specific Immunotherapy”

346 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 346 results

Large-scale testing (Phase 3)Study completedNCT00263601
What this trial is testing

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Grass Pollen Allergy
Allergopharma GmbH & Co. KG 154
Not applicableStudy completedNCT04389034
What this trial is testing

Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels

Who this might be right for
Rhinitis, AllergicRespiratory Tract InfectionsAllergy+2 more
Allergy Therapeutics 113
Early research (Phase 1)Looking for participantsNCT04020575
What this trial is testing

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

Who this might be right for
Metastatic Breast Cancer
Minerva Biotechnologies Corporation 69
Testing effectiveness (Phase 2)UnknownNCT00036426
What this trial is testing

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-Grade
Favrille 22
Early research (Phase 1)Study completedNCT00057915
What this trial is testing

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Duke University 4
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Early research (Phase 1)Active Not RecruitingNCT02792114
What this trial is testing

T-Cell Therapy for Advanced Breast Cancer

Who this might be right for
Breast CancerMetastatic HER2-negative Breast
Memorial Sloan Kettering Cancer Center 186
Testing effectiveness (Phase 2)Study completedNCT00004022
What this trial is testing

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00228189
What this trial is testing

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Radboud University Medical Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05587374
What this trial is testing

Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal Cancer
Sun Yat-sen University 490
Early research (Phase 1)Active Not RecruitingNCT03500991
What this trial is testing

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Who this might be right for
Central Nervous System Tumor, PediatricGliomaEpendymoma+6 more
Seattle Children's Hospital 10
Early research (Phase 1)Study completedNCT00110578
What this trial is testing

Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT02261714
What this trial is testing

Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Resected
Targovax ASA 32
Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT01240447
What this trial is testing

Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Advanced Non-small Cell Lung Cancer
Laboratorio Elea Phoenix S.A. 7
Early research (Phase 1)Study completedNCT00101257
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT01220128
What this trial is testing

Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 66
Early research (Phase 1)Ended earlyNCT03396575
What this trial is testing

Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)

Who this might be right for
Diffuse Intrinsic Pontine Glioma (DIPG)Brain Stem Glioma
University of Florida 11
Not applicableUnknownNCT02667093
What this trial is testing

Samples From Leukemia Patients and Their Donors to Identify Specific Antigens

Who this might be right for
Acute Myeloid Leukemia
PersImmune, Inc 50
Testing effectiveness (Phase 2)Study completedNCT00777374
What this trial is testing

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration

Who this might be right for
Allergic Rhinoconjunctivitis
University of Zurich 97
Load More Results